Repurposing Licensed Drugs with Activity Against Epstein–Barr Virus for Treatment of Multiple Sclerosis: A Systematic Approach

Vivien Li, Fiona C. McKay, David C. Tscharke, Corey Smith, Rajiv Khanna, Jeannette Lechner‐Scott, William D. Rawlinson, Andrew R. Lloyd, Bruce Taylor, Julia M. Morahan, Lawrence Steinman, Gavin Giovannoni, Amit Bar‐Or, Michael Levy, Natalia Drosu, Andrew Potter, Nigel Caswell, Lynne M. Smith, Erin C. Brady, B Frost, Suzanne Hodgkinson, Todd A. Hardy, Simon Broadley, the Australian Anti-EBV Drugs for MS Working Group